Gen-Probe Inc. (NSDQ:GPRO) bought Waukesha, Wis.-based GTI Diagnostics in a self-funded $53 million cash deal. The acquisition allows the San Diego-based company to expand its transplant diagnostics ...

Epigenetic modifications such as DNA methylation play a key role in regulating gene expression. Emerging evidence suggests that intermediates generated during DNA demethylation may have distinct ...

NEW YORK, July 30 (Reuters) - Gen-Probe Inc reported second-quarter net profit fell 20 percent on the impact of a stronger dollar and acquisition costs, and it lowered the top-end of its full-year ...

SAN FRANCISCO (MarketWatch) -- Gen-Probe Inc. Wednesday evening said it has formed an exclusive collaboration with 3M Co. to develop, manufacture and market nucleic acid tests to enhance food safety.

BOSTON (CBS.MW) -- Biotechnology stocks gained ground Friday, with shares of Gen-Probe among the upside standouts after the small biotech firm said it filed for regulatory approval for a new system to ...

Diagnostic products maker Gen-Probe Inc. (:GPRO) has secured the approval of the U.S. Food and Drug Administration ("FDA") for its PROGENSA PCA3 assay, a novel molecular test designed to aid the ...

announced today that the Company has acquired GTI Diagnostics, a privately held specialty diagnostics company focused on the transplantation, blood bank and specialty coagulation markets, for $53 ...

Good afternoon, I would like to thank all participants for holding. All lines will be on listen-only until the Question and Answer portion of today's conference, and I would also like to inform all ...

Real-time PCR assays are valuable tools for the rapid and accurate diagnosis of infectious diseases by identifying the nucleic acid sequences of pathogens. Here, we aimed to develop a recombinant ...

NEW YORK, Feb 13 (Reuters) - Gen-Probe Inc on Wednesday said its fourth-quarter earnings rose on a favorable tax rate and higher sales of its clinical diagnostics products and tests used to screen ...